Short communication: Quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidity

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 179-182

  Pendyala, Gurudutt ^a,b   Trauger, Sunia A ^b   Siuzdak, Gary ^b   Fox, Howard S ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; METHAMPHETAMINE; SUPEROXIDE DISMUTASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMORBIDITY; CONTROLLED STUDY; HOST RESISTANCE; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; QUANTITATIVE PROTEOMIC PLASMA PROFILING; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SUBSTANCE ABUSE; UPREGULATION; VIRUS LOAD;

ANIMALS; BLOOD PROTEINS; CHRONIC DISEASE; HUMANS; METHAMPHETAMINE; OXIDATIVE STRESS; PROTEOMICS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 79951701760     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0090     Document Type: Article

References (26)

1. Degenhardt L, Mathers B, Guarinieri M, et al.: Methamphetamine use and associated HIV: Implications for global policy and public health. Int J Drug Policy 2010;21(5): 347-358.
2. Cadet JL and Krasnova IN: Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 2007;12(3):181-204.
3. Theodore S, Stolberg S, Cass WA, and Maragos WF: Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Ann NY Acad Sci 2006;1074: 178-190. (Pubitemid 44532823)
4. Shaw LM, Korecka M, Clark CM, Lee VM, and Trojanowski JQ: Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 2007;6(4): 295-303. (Pubitemid 46505880)
5. Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, and Fox HS: Susceptibility of Chinese rhesus monkeys to SIV infection. AIDS 2005;19(15):1704-1706. (Pubitemid 41502689)
6. Watry D, Lane TE, Streb M, and Fox HS: Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol 1995;146(4):914-923.
7. Madden LJ, Flynn CT, Zandonatti MA, et al.: Modeling human methamphetamine exposure in nonhuman primates: Chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 2005;30(2):350-359. (Pubitemid 40129486)
8. Thompson PM, Hayashi KM, Simon SL, et al.: Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004;24(26):6028-6036. (Pubitemid 38859399)
9. Marcondes MC, Flynn C, Watry DD, Zandonatti M, and Fox HS: Methamphetamine increases brain viral load and activates NK cells in SIV-infected monkeys. Am J Pathol 2010;177:355-361.
10. Pendyala G, Trauger SA, Siuzdak G, and Fox HS: Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J Proteome Res 2010;9(1):352-358.
11. Perez-Casanova A, Husain K, Noel RJ, Jr., Rivera-Amill V, and Kumar A: Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque. Mol Cell Biochem 2008;308(1-2):169-175. (Pubitemid 351167858)
12. Perez-Casanova A, Noel RJ, Jr., Rivera-Amill V, Husain K, and Kumar A: Morphine-mediated deterioration of oxidative stress leads to rapid disease progression in SIV/SHIVinfected macaques. AIDS Res Hum Retroviruses 2007;23(8): 1004-1007. (Pubitemid 47492341)
13. Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, and Sonsalla PK: Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 2001;79(1):152-160. (Pubitemid 32946652)
14. Harold C, Wallace T, Friedman R, Gudelsky G, and Yamamoto B: Methamphetamine selectively alters brain glutathione. Eur J Pharmacol 2000;400(1):99-102. (Pubitemid 30412114)
15. Jayanthi S, Ladenheim B, and Cadet JL: Methamphetamineinduced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann NY Acad Sci 1998;844:92-102. (Pubitemid 28367798)
16. Ali SF, Martin JL, Black MD, and Itzhak Y: Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine- induced dopaminergic neurotoxicity. Ann NY Acad Sci 1999;890:119. (Pubitemid 30040370)
17. De Vito MJ and Wagner GC: Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 1989;28(10):1145-1150. (Pubitemid 19254411)
18. Fukami G, Hashimoto K, Koike K, Okamura N, Shimizu E, and Iyo M: Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 2004;1016(1):90-95. (Pubitemid 38834276)
19. Imam SZ and Ali SF: Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 2000;855(1):186-191. (Pubitemid 30067713)
20. Cadet JL, Ali S, and Epstein C: Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: Evidence from the use of CuZnSOD transgenic mice. Ann NY Acad Sci 1994;738:388-391.
21. Hirata H, Ladenheim B, Carlson E, Epstein C, and Cadet JL: Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 1996; 714(1-2):95-103. (Pubitemid 26122275)
22. Li W, Malpica-Llanos TM, Gundry R, et al.: Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity. Neurology 2008;70(19 Pt 2):1753-1762. (Pubitemid 351653962)
23. Hayes JD, Flanagan JU, and Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88. (Pubitemid 40261798)
24. Matsushita M, Thiel S, Jensenius JC, Terai I, and Fujita T: Proteolytic activities of two types of mannose-binding lectinassociated serine protease. J Immunol 2000;165(5):2637-2642. (Pubitemid 30660711)
25. Thiel S, Vorup-Jensen T, Stover CM, et al.: A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997;386(6624):506-510. (Pubitemid 27164078)
26. Nelson RA, Jr., Jensen J, Gigli I, and Tamura N: Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry 1966;3(2):111-135.